Harrison's Manual of Oncology
Published on 16. January 2008
Book
Paperback/Softback
644 pages
978-0-07-141189-9 (ISBN)
Description
The full spectrum of oncology medications -- backed by the authority of Harrison's!From today's leading clinicians in cancer care comes this comprehensive yet portable guide to the major chemotherapeutic and supportive care agents in oncology. Full of never-before-published content, this invaluable clinical companion features numerous tables and a concise, outline-oriented text, making it ideal for reference at a glance.
Features::
A complete overview of all medications used in cancer care, including hormonal agents and biologic response modifiers
Tables and templated format clearly highlight each drug and its companion regimen
Clinically relevant and prescriptive approach emphasizes precise dosing regimens and potential combinations for tailoring multi-drug regimens
Section on supportive and palliative care
A review of high-dose therapy and bone marrow transplant
Content that goes beyond the treatment of primary or metastatic disease to encompass the treatment of all therapeutic complications
Features::
A complete overview of all medications used in cancer care, including hormonal agents and biologic response modifiers
Tables and templated format clearly highlight each drug and its companion regimen
Clinically relevant and prescriptive approach emphasizes precise dosing regimens and potential combinations for tailoring multi-drug regimens
Section on supportive and palliative care
A review of high-dose therapy and bone marrow transplant
Content that goes beyond the treatment of primary or metastatic disease to encompass the treatment of all therapeutic complications
More details
Language
English
Place of publication
New York
United States
Publishing group
McGraw-Hill Education - Europe
Target group
Professional and scholarly
Dimensions
Height: 211 mm
Width: 119 mm
Thickness: 23 mm
Weight
555 gr
ISBN-13
978-0-07-141189-9 (9780071411899)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Bruce Chabner | Thomas Lynch | Dan Longo
Harrisons Manual of Oncology 2/E
Book
01/2014
2nd Edition
McGraw-Hill Medical
€88.00
Article not available at the moment
Persons
Bruce Chabner, MD Professor of Medicine Harvard Medical School Director, Massachusetts General Hospital Cancer Center Boston, MA
Dan L. Longo, MDScientific DirectorNational Institute on AgingNational Institutes of HealthBethesda, Maryland
Dan L. Longo, MDScientific DirectorNational Institute on AgingNational Institutes of HealthBethesda, Maryland
Content
Contributors
Preface
Acknowledgments
Introduction to Cancer Pharmacology, Bruce A. Chabner
Section 1: Classes of Drugs
1. Antimetabolites: Fluoropyrimidines and Other Agents, Bruce A. Chabner
2. Antifolates, Bruce A. Chabner
3. The Taxanes and Their Derivatives, Hamza Mujagic and Bruce A. Chabner
4. Vinca Alkaloids, Bruce A. Chabner
5. Topoisomerase Inhibitors: Camptothecins, Anthracyclines, and Etoposide, Dan Zuckerman and Bruce A. Chabner
6. Adduct-Forming Agents: Alkylating Agents and Platinum Analogs, Bruce A. Chabner
7. Thalidomide and Its Analogs, Hamza Mujagic
8. Bleomycin, Bruce A. Chabner
9. L-Asparaginase, Bruce A. Chabner
10. Molecular Targeted Drugs, Jeffrey W. Clark
11. Differentiating Agents, Bruce A. Chabner
Section 2: Hormonal Agents
12. Hormonal Agents: Antiestrogens, Kathrin Strasser-Weippl and Paul E. Goss
13. Antiandrogen Therapy, Bruce A. Chabner
Section 3: Biologic Response Modifiers
14. Interferons, Dan L. Longo
15. Cytokines, Growth Factors, and Immune-Based Interventions, Dan L. Longo
16. Monoclonal Antibodies in Cancer Treatment, Dan L. Longo
Section 4: Supportive Care
17. Bisphosphonates, Matthew R. Smith
18. Febrile Neutropenia, Mark C. Poznansky and Fabrizio Vianello
19. Anemia, James E. Bradner
20. Cancer and Coaguloapthy, Rachel P.G. Rosovsky
21. Metabolic Emergencies in Oncology, Elizabeth Trice and Ephraim Paul Hochberg
22. Pain Management, Juliet Jacobsen and Vicki Jackson
23. Comprehensive End-of-Life Care, Jennifer Temel
24. Depression, Anxiety, and Fatigue, William F. Pirl
25. Respiratory Emergencies, Tracey Evans
Section 5: Myeloid Malignancies
26. Myeloid Malignancies, Karen Ballen
Section 6: Lymphoid Malignancies
27. Hodgkin's Disease, Dan L. Longo
28. Non-Hodgkin's Lymphoma, Yi-Bin Chen and Ephraim Paul Hochberg
29. Acute Lymphoblastic Leukemia and Lymphoma, Eyal C. Attar and Janet E. Murphy
30. Chronic Lymphocytic Leukemia, Philip C. Amrein
31. Plasma Cell Disorders, Noopur Raje and Dan L. Longo
Section 7: Myelodysplastic Syndromes
32. Myelodysplastic Syndromes, Eyal C. Attar
Section 8: Myeloproliferative Syndromes
33. Polycythemia Vera, Jerry L. Spivak
34. Idiopathic Myelofibrosis, Jerry L. Spivak
35. Essential Thrombocytosis, Jerry L. Spivak
Section 9: High-Dose Therapy and Bone Marrow Transplant
36. High-Dose Chemotherapy, Yi-Bin Chen
37. Bone Marrow Transplantation, Thomas R. Spitzer
Section 10: GU Oncology
38. Renal Cell Carcinoma, Abraham B. Schwarzberg and M. Dror Michaelson
39. Localized Prostate Cancers, John J. Coen and Douglas M. Dahl
40. Testicular Cancer, Timothy Gilligan
41. Bladder Cancer, Donald S. Kaufman
42. Advanced Prostate Cancer, Matthew R. Smith
Section 11: GI Oncology
43. Esophageal Cancer, Geoffrey Liu
44. Gastric Cancer, Lawrence S. Blaszkowsky
45. Pancreative Cancer, Jeffrey W. Clark
46. Hepatocellular Carcinoma, Andrew X. Zhu
47. Cholangiocarcinoma and Gallbladder Cancers, Andrew X. Zhu
48. Colon Cancer, David P. Ryan
49. Rectal Cancer, Brian M. Alexander and Theodore S. Hong
50. Anal Cancer, Johanna Bendell
Section 13: Thoracic Oncology
51. Malignant Mesothelioma, Pasi A. Jaenne
52. Non-Small Cell Lung Cancer, Lecia V. Sequist
53. Review of Clinical Trials in Thymoma, Panos Fidias
54. Small Cell Lung Cancer, Rebecca Suk Heist
Section 13: Gyn Oncology
55. Ovarian Cancer, Richard T. Penson
56. Primary Squamous Carcinoma of the Uterine Cervix: Diagnosis and Management, Marcela G. del Carmen
57. Uterine Cancer, Carolyn Krasner
Section 14: Breast Oncology
58. Breast Oncology: Clinical Presentation and Genetics, Tessa Cigler and Paula D. Ryan
59. Localized Breast Cancer, Beverly Moy
60. Metastatic Breast Cancer, Steven J. Isakoff and Paula D. Ryan
Section 15: Melanoma
61. Melanoma, Donald P. Lawrence and Krista M. RubinSection 16: Sarcoma
62. Soft Tissue and Bone Sarcomas, Sam S. Yoon, Francis J. Hornicek, David C. Harmon, and Thomas F. DeLaney
Section 17: Neuro-Oncology
63. Primary Brain Tumors, Andrew S. Chi and Tracy T. Batchelor
64. Metastatic Brain Tumors, April F. Eichler and Scott R. Plotkin
65. Paraneoplastic Neurologic Syndromes, Kathryn J. Ruddy and Fred H. Hochberg
Section 18: Head and Neck Cancer
66. Head and Neck Cancer, John R. Clark, Paul M. Busse, and Daniel Deschler
Index
Preface
Acknowledgments
Introduction to Cancer Pharmacology, Bruce A. Chabner
Section 1: Classes of Drugs
1. Antimetabolites: Fluoropyrimidines and Other Agents, Bruce A. Chabner
2. Antifolates, Bruce A. Chabner
3. The Taxanes and Their Derivatives, Hamza Mujagic and Bruce A. Chabner
4. Vinca Alkaloids, Bruce A. Chabner
5. Topoisomerase Inhibitors: Camptothecins, Anthracyclines, and Etoposide, Dan Zuckerman and Bruce A. Chabner
6. Adduct-Forming Agents: Alkylating Agents and Platinum Analogs, Bruce A. Chabner
7. Thalidomide and Its Analogs, Hamza Mujagic
8. Bleomycin, Bruce A. Chabner
9. L-Asparaginase, Bruce A. Chabner
10. Molecular Targeted Drugs, Jeffrey W. Clark
11. Differentiating Agents, Bruce A. Chabner
Section 2: Hormonal Agents
12. Hormonal Agents: Antiestrogens, Kathrin Strasser-Weippl and Paul E. Goss
13. Antiandrogen Therapy, Bruce A. Chabner
Section 3: Biologic Response Modifiers
14. Interferons, Dan L. Longo
15. Cytokines, Growth Factors, and Immune-Based Interventions, Dan L. Longo
16. Monoclonal Antibodies in Cancer Treatment, Dan L. Longo
Section 4: Supportive Care
17. Bisphosphonates, Matthew R. Smith
18. Febrile Neutropenia, Mark C. Poznansky and Fabrizio Vianello
19. Anemia, James E. Bradner
20. Cancer and Coaguloapthy, Rachel P.G. Rosovsky
21. Metabolic Emergencies in Oncology, Elizabeth Trice and Ephraim Paul Hochberg
22. Pain Management, Juliet Jacobsen and Vicki Jackson
23. Comprehensive End-of-Life Care, Jennifer Temel
24. Depression, Anxiety, and Fatigue, William F. Pirl
25. Respiratory Emergencies, Tracey Evans
Section 5: Myeloid Malignancies
26. Myeloid Malignancies, Karen Ballen
Section 6: Lymphoid Malignancies
27. Hodgkin's Disease, Dan L. Longo
28. Non-Hodgkin's Lymphoma, Yi-Bin Chen and Ephraim Paul Hochberg
29. Acute Lymphoblastic Leukemia and Lymphoma, Eyal C. Attar and Janet E. Murphy
30. Chronic Lymphocytic Leukemia, Philip C. Amrein
31. Plasma Cell Disorders, Noopur Raje and Dan L. Longo
Section 7: Myelodysplastic Syndromes
32. Myelodysplastic Syndromes, Eyal C. Attar
Section 8: Myeloproliferative Syndromes
33. Polycythemia Vera, Jerry L. Spivak
34. Idiopathic Myelofibrosis, Jerry L. Spivak
35. Essential Thrombocytosis, Jerry L. Spivak
Section 9: High-Dose Therapy and Bone Marrow Transplant
36. High-Dose Chemotherapy, Yi-Bin Chen
37. Bone Marrow Transplantation, Thomas R. Spitzer
Section 10: GU Oncology
38. Renal Cell Carcinoma, Abraham B. Schwarzberg and M. Dror Michaelson
39. Localized Prostate Cancers, John J. Coen and Douglas M. Dahl
40. Testicular Cancer, Timothy Gilligan
41. Bladder Cancer, Donald S. Kaufman
42. Advanced Prostate Cancer, Matthew R. Smith
Section 11: GI Oncology
43. Esophageal Cancer, Geoffrey Liu
44. Gastric Cancer, Lawrence S. Blaszkowsky
45. Pancreative Cancer, Jeffrey W. Clark
46. Hepatocellular Carcinoma, Andrew X. Zhu
47. Cholangiocarcinoma and Gallbladder Cancers, Andrew X. Zhu
48. Colon Cancer, David P. Ryan
49. Rectal Cancer, Brian M. Alexander and Theodore S. Hong
50. Anal Cancer, Johanna Bendell
Section 13: Thoracic Oncology
51. Malignant Mesothelioma, Pasi A. Jaenne
52. Non-Small Cell Lung Cancer, Lecia V. Sequist
53. Review of Clinical Trials in Thymoma, Panos Fidias
54. Small Cell Lung Cancer, Rebecca Suk Heist
Section 13: Gyn Oncology
55. Ovarian Cancer, Richard T. Penson
56. Primary Squamous Carcinoma of the Uterine Cervix: Diagnosis and Management, Marcela G. del Carmen
57. Uterine Cancer, Carolyn Krasner
Section 14: Breast Oncology
58. Breast Oncology: Clinical Presentation and Genetics, Tessa Cigler and Paula D. Ryan
59. Localized Breast Cancer, Beverly Moy
60. Metastatic Breast Cancer, Steven J. Isakoff and Paula D. Ryan
Section 15: Melanoma
61. Melanoma, Donald P. Lawrence and Krista M. RubinSection 16: Sarcoma
62. Soft Tissue and Bone Sarcomas, Sam S. Yoon, Francis J. Hornicek, David C. Harmon, and Thomas F. DeLaney
Section 17: Neuro-Oncology
63. Primary Brain Tumors, Andrew S. Chi and Tracy T. Batchelor
64. Metastatic Brain Tumors, April F. Eichler and Scott R. Plotkin
65. Paraneoplastic Neurologic Syndromes, Kathryn J. Ruddy and Fred H. Hochberg
Section 18: Head and Neck Cancer
66. Head and Neck Cancer, John R. Clark, Paul M. Busse, and Daniel Deschler
Index